The biotechnology sector, mainly due to its multidisciplinary approach, holds the potential to provide an array of solutions for challenges in various sectors such as health, agriculture, environment, energy and industrial processes. The global biotechnology market size was valued at USD 752.88 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.83% from 2021 to 2028.
By 2025, contribution of the Indian biotechnology industry in the global biotechnology market is expected to increase to ~19%. India is among the top 12 biotechnology destinations in the world and the 3rd largest in Asia-Pacific. The Indian bioeconomy grew from US$ 62.5 billion in 2019 to US$ 70.2 billion in 2020 at a growth rate of 12.3% and is likely to register a CAGR of 16.4% to reach US$ 150 billion by 2025.
The Indian biotech industry consists of 4,240 biotech start-ups and is expected to grow to 10,000 by 2024. As of February 2022, India has almost 5000 biotech companies. India has 665 FDA-approved plants outside of the US, which is the highest in the world. India also has 44% share of the global abbreviated new drug applications (ANDA) and >1400 manufacturing plants which comply with WHO requirements. As of 2020, biopharmaceuticals contributed 62% to the Indian bioeconomy, followed by bio-agriculture (16%), bio-services (15%) and bio-industrial (7%).
4-Yr B.Tech. Biotechnology program with possibility to continue into integrated 5-Yr M.Tech. Biotechnology.